Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
Fortune -

For most CEOs in the U.K., a salary exceeding $20 million is the stuff of dreams. However, for AstraZeneca's CEO, it appears to be sparking...

Related Articles

Latest in News

More from Fortune | AstraZeneca CEO salaries and executive compensation european economy Novartis Novo Nordisk Ozempic Pharmaceutical Industry retail Roche U.K. Dividend Pascal Soriot